These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 5161339

  • 1. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
    Clark WG, Corrodi H, Masuoka DT.
    Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
    [No Abstract] [Full Text] [Related]

  • 2. Relationship between catecholamines and serotonin in sympathetic nerves of the rat pineal gland.
    Zweig M, Axelrod J.
    J Neurobiol; 1969 Jun; 1(1):87-97. PubMed ID: 4400911
    [No Abstract] [Full Text] [Related]

  • 3. Effects of social stress on the turnover of brain catecholamines and 5-hydroxytryptamine in mice.
    Modigh K.
    Acta Pharmacol Toxicol (Copenh); 1974 Feb; 34(2):97-105. PubMed ID: 4545032
    [No Abstract] [Full Text] [Related]

  • 4. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
    Morgan CD, Cattabeni F, Costa E.
    J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
    [No Abstract] [Full Text] [Related]

  • 5. Brain amine levels and competitive behavior between rats in a straight runway.
    Masur J, Czeresnia S, Skitnevsky H, Carlini EA.
    Pharmacol Biochem Behav; 1974 Jan; 2(1):55-62. PubMed ID: 4275179
    [No Abstract] [Full Text] [Related]

  • 6. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE.
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract] [Full Text] [Related]

  • 7. The effect of (+-)-p-chloroamphetamine on the susceptiblity to seizures and on the monoamine level in brain and heart of mice and rats.
    Pfeifer AK, Galambos E.
    J Pharm Pharmacol; 1967 Jun; 19(6):400-2. PubMed ID: 4382372
    [No Abstract] [Full Text] [Related]

  • 8. Response of neurogenic amines to aggregation and strangers.
    Bliss EL, Ailion J.
    J Pharmacol Exp Ther; 1969 Aug; 168(2):258-63. PubMed ID: 5816819
    [No Abstract] [Full Text] [Related]

  • 9. Correlation of brain catecholamines with cortical acetylcholine outflow, behaviour and electrocorticogram.
    Beani L, Bianchi C, Castellucci A.
    Eur J Pharmacol; 1974 Apr; 26(1):63-72. PubMed ID: 4831985
    [No Abstract] [Full Text] [Related]

  • 10. Relationship of brain dopamine to stress-induced changes in seizure susceptibility.
    Goldberg ME, Salama AI.
    Eur J Pharmacol; 1970 Apr; 10(3):333-8. PubMed ID: 5422459
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of catecholamine synthesis and conditioned avoidance acquisition.
    Ahlenius S.
    Pharmacol Biochem Behav; 1973 Apr; 1(3):347-50. PubMed ID: 4775861
    [No Abstract] [Full Text] [Related]

  • 12. Effect of 6-hydroxydopamine on brain norepinephrine and dopamine evidence for selective degeneration of catecholamine neurons.
    Breese GR, Traylor TD.
    J Pharmacol Exp Ther; 1970 Sep; 174(3):413-20. PubMed ID: 5456173
    [Abstract] [Full Text] [Related]

  • 13. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE, Aghajanian GK.
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ, Littleton JM, Oritz A, Brownlee G.
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract] [Full Text] [Related]

  • 16. The effect of psychotomimetic glycolate esters on central monoamine neurons.
    Andén NE, Corrodi H, Fuxe K.
    Eur J Pharmacol; 1972 Jan; 17(1):97-102. PubMed ID: 4401437
    [No Abstract] [Full Text] [Related]

  • 17. Shock-induced aggression: effects of 6-hydroxydopamine and other pharmacological agents.
    Thoa NB, Eichelman B, Ng LK.
    Brain Res; 1972 Aug 25; 43(2):467-75. PubMed ID: 5066136
    [No Abstract] [Full Text] [Related]

  • 18. A reliable method for the simultaneous estimation of dopamine, noradrenaline and serotonin in discrete areas of brain.
    Butterworth RF, Landreville F, Guitard M, Barbeau A.
    Clin Biochem; 1975 Oct 25; 8(5):298-302. PubMed ID: 1201621
    [Abstract] [Full Text] [Related]

  • 19. Lesions of central norepinephrine terminals with 6-OH-dopamine: biochemistry and fine structure.
    Bloom FE, Algeri S, Groppetti A, Revuelta A, Costa E.
    Science; 1969 Dec 05; 166(3910):1284-6. PubMed ID: 5350323
    [Abstract] [Full Text] [Related]

  • 20. Differential activation by restraint stress of a mechanism to conserve brain catecholamines and serotonin in mice differing in excitability.
    Welch BL, Welch AS.
    Nature; 1968 May 11; 218(5141):575-7. PubMed ID: 5655184
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.